THE ANTI-CD40 MAB ISCALIMAB (CFZ533) DOES NOT IMPAIR IMMUNE EBV CONTROLTina Rubic-Schneider,Deborah Garcia,Martine Marchant,Brigitte Christen,Nathalie Runser-Loll,James Rush,Elisabetta Traggiai,Peter UlrichTRANSPLANT INTERNATIONAL(2019)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要